MYC on the Path to Cancer

被引:2667
作者
Dang, Chi V. [1 ]
机构
[1] Univ Penn, Perelman Sch Med, Abramson Canc Ctr,Div Hematol Oncol, Abramson Family Canc Res Inst,Dept Med, Philadelphia, PA 19104 USA
基金
美国国家卫生研究院;
关键词
ONCOGENE-INDUCED SENESCENCE; ENDOTHELIAL GROWTH-FACTOR; LONG-RANGE INTERACTION; C-MYC; N-MYC; IN-VIVO; TRANSCRIPTIONAL ACTIVATION; BURKITT-LYMPHOMA; GENE-EXPRESSION; DROSOPHILA-MYC;
D O I
10.1016/j.cell.2012.03.003
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The MYC oncogene contributes to the genesis of many human cancers. Recent insights into its expression and function have led to therapeutic opportunities. MYC's activation by bromodomain proteins could be inhibited by drug-like molecules, resulting in tumor inhibition in vivo. Tumor growth can also be curbed by pharmacologically uncoupling bioenergetic pathways involving glucose or glutamine metabolism from Myc-induced cellular biomass accumulation. Other approaches to halt Myc on the path to cancer involve targeting Myc-Max dimerization or Myc-induced microRNA expression. Here the richness of our understanding of MYC is reviewed, highlighting new biological insights and opportunities for cancer therapies.
引用
收藏
页码:22 / 35
页数:14
相关论文
共 228 条
[31]   In Vitro Cytotoxicity and In Vivo Efficacy, Pharmacokinetics, and Metabolism of 10074-G5, a Novel Small-Molecule Inhibitor of c-Myc/Max Dimerization [J].
Clausen, Dana M. ;
Guo, Jianxia ;
Parise, Robert A. ;
Beumer, Jan H. ;
Egorin, Merrill J. ;
Lazo, John S. ;
Prochownik, Edward V. ;
Eiseman, Julie L. .
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2010, 335 (03) :715-727
[32]   Transcription-independent functions of MYC: regulation of translation and DNA replication [J].
Cole, Michael D. ;
Cowling, Victoria H. .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2008, 9 (10) :810-815
[33]   Myc-Nick: A Cytoplasmic Cleavage Product of Myc that Promotes α-Tubulin Acetylation and Cell Differentiation [J].
Conacci-Sorrell, Maralice ;
Ngouenet, Celine ;
Eisenman, Robert N. .
CELL, 2010, 142 (03) :480-493
[34]   A conserved Myc protein domain, MBIV, regulates DNA binding, apoptosis, transformation, an G2 arrest [J].
Cowling, Victoria H. ;
Chandriani, Sanjay ;
Whitfield, Michael L. ;
Cole, Michael D. .
MOLECULAR AND CELLULAR BIOLOGY, 2006, 26 (11) :4226-4239
[35]   c-MYC induces mammary tumorigenesis by means of a preferred pathway involving spontaneous Kras2 mutations [J].
D'Cruz, CM ;
Gunther, EJ ;
Boxer, RB ;
Hartman, JL ;
Sintasath, L ;
Moody, SE ;
Cox, JD ;
Ha, SI ;
Belka, GK ;
Golant, A ;
Cardiff, RD ;
Chodosh, LA .
NATURE MEDICINE, 2001, 7 (02) :235-239
[36]   Solution Structure of a 2:1 Quindoline-c-MYC G-Quadruplex: Insights into G-Quadruplex-Interactive Small Molecule Drug Design [J].
Dai, Jixun ;
Carver, Megan ;
Hurley, Laurence H. ;
Yang, Danzhou .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2011, 133 (44) :17673-17680
[37]   HUMAN C-MYC ONC GENE IS LOCATED ON THE REGION OF CHROMOSOME-8 THAT IS TRANSLOCATED IN BURKITT-LYMPHOMA CELLS [J].
DALLAFAVERA, R ;
BREGNI, M ;
ERIKSON, J ;
PATTERSON, D ;
GALLO, RC ;
CROCE, CM .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1982, 79 (24) :7824-7827
[38]   The interplay between MYC and HIF in the Warburg effect [J].
Dang, C. V. .
ONCOGENES MEET METABOLISM: FROM DEREGULATED GENES TO A BROADER UNDERSTANDING OF TUMOUR PHYSIOLOGY, 2008, 4 :35-53
[39]   Hypoxia and metabolism - Opinion - The interplay between MYC and HIF in cancer [J].
Dang, Chi V. ;
Kim, Jung-whan ;
Gao, Ping ;
Yustein, Jason .
NATURE REVIEWS CANCER, 2008, 8 (01) :51-56
[40]   The c-Myc target gene network [J].
Dang, Chi V. ;
O'Donnell, Kathryn A. ;
Zeller, Karen I. ;
Nguyen, Tam ;
Osthus, Rebecca C. ;
Li, Feng .
SEMINARS IN CANCER BIOLOGY, 2006, 16 (04) :253-264